This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramsay, P. L.
Right arrow Articles by Welty, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramsay, P. L.
Right arrow Articles by Welty, S. E.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 102 No. 4 October 1998, pp. 927-932

Early Clinical Markers for the Development of Bronchopulmonary Dysplasia: Soluble E-Selectin and ICAM-1

Received Jan 23, 1998; accepted Mar 27, 1998.

Patricia L. Ramsay, E. O'Brian Smith, Suzanne Hegemier, and Stephen E. Welty

From the Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

Objective.  To test the hypothesis that in infants born at <= 29 weeks' gestation soluble adhesion molecule concentrations would be higher in the first week of life in infants that subsequently develop bronchopulmonary dysplasia than in infants that do not.

Design and Methods.  In cord blood and on days of life 1, 3, and 7, we measured serum concentrations of soluble P-Selectin, E-Selectin, and intercellular adhesion molecule-1 in samples obtained from infants <= 29 weeks' gestational age. At 1 month of age we assessed the infants' clinical courses to determine whether the infants met the criteria for the diagnosis of bronchopulmonary dysplasia (BPD) and evaluated the infants' radiographic studies to stage the level of BPD. On discharge, the duration of oxygen therapy, the requirement for home oxygen therapy, and length of hospital stay were determined.

Results.  Concentrations of soluble P-Selectin were greatest in cord blood samples obtained from all infants and were markedly reduced on day of life 1, regardless of the subsequent development of BPD. In serum samples obtained from cord blood and on days of life 1 and 3, soluble E-Selectin levels were higher in infants that developed BPD than in infants that did not develop BPD. In addition, the highest concentrations of soluble E-Selectin in serum samples from cord blood and on day of life 1 were associated with the development of stage 3 or 4 BPD. Soluble intercellular adhesion molecule-1 concentrations were higher on days of life 3 and 7 in the infants that went on to develop BPD than in those that did not.

Conclusions.  Because neutrophil attachment to endothelial cell adhesion molecules is a key event in the initiation of an inflammatory response, the association of higher early concentrations of soluble E-Selectin with the development of BPD suggests that E-Selectin may play a key role in the pathogenesis of lung inflammation and the development of BPD. This association also suggests that inflammatory events or effects leading to inflammatory responses occurring in the prenatal and/or very early perinatal periods contribute significantly to the pathogenesis of BPD.  Key words:  bronchopulmonary dysplasia, infant, newborn, cell adhesion molecules, lung diseases.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
A Bourbia, M A Cruz, and H J Rozycki
NF-{kappa}B in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2006; 91(1): F36 - F39.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. Hsiao and S. A. Omar
Outcome of Extremely Low Birth Weight Infants With Leukemoid Reaction
Pediatrics, July 1, 2005; 116(1): e43 - e51.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
H. Christou and D. Brodsky
Lung Injury and Bronchopulmonary Dysplasia in Newborn Infants
J Intensive Care Med, March 1, 2005; 20(2): 76 - 87.
[Abstract] [PDF]

Home page
 LupusHome page
M W Beresford, A G Cleary, J A Sills, J Couriel, and J E Davidson
Cardio-pulmonary involvement in juvenile systemic lupus erythematosus
Lupus, February 1, 2005; 14(2): 152 - 158.
[Abstract] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
P Ballabh, M Simm, J Kumari, A N Krauss, A Jain, C Califano, M L Lesser, and S Cunningham-Rundles
Neutrophil and monocyte adhesion molecules in bronchopulmonary dysplasia, and effects of corticosteroids
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2004; 89(1): F76 - F83.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. Ballabh, J. Kumari, A. N. Krauss, J. J. Shin, A. Jain, P. A. M. Auld, M. L. Lesser, and S. Cunningham-Rundles
Soluble E-Selectin, Soluble L-Selectin and Soluble ICAM-1 in Bronchopulmonary Dysplasia, and Changes With Dexamethasone
Pediatrics, March 1, 2003; 111(3): 461 - 468.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. L. RAMSAY, F. J. DeMAYO, S. E. HEGEMIER, M. E. WEARDEN, C. V. SMITH, and S. E. WELTY
Clara Cell Secretory Protein Oxidation and Expression in Premature Infants Who Develop Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 155 - 161.
[Abstract] [Full Text] [PDF]